Understanding how memory B cells respond to vaccines in mice
Characterization of iGL-VRC01 Memory B cell Responses in Mice
This study is looking at how memory B cells in mice work, which could help us create better vaccines by understanding how things like the strength of the immune response and timing of shots affect these important cells when they fight infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11076149 on NIH RePORTER |
What this research studies
This research investigates the behavior of memory B cells in mice, which are crucial for developing effective vaccines. The team will explore how different factors, such as the strength of the immune response and the timing of vaccination, influence the ability of these cells to respond to infections. By using a mouse model, they aim to generate specific types of memory B cells and assess how these cells behave when exposed to various antigens. This work could provide insights that enhance vaccine design for better protection against diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would include individuals with conditions that could be treated or prevented by vaccines, particularly those related to B cell function.
Not a fit: Patients with conditions unrelated to B cell responses or those not requiring vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine strategies that enhance immune responses in patients.
How similar studies have performed: Previous research has shown promising results in understanding B cell memory responses, suggesting that this approach could yield valuable insights.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Voss, James Even — Scripps Research Institute, the
- Study coordinator: Voss, James Even
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.